1 |
35885481 |
10.3390/diagnostics12071575 |
2022 |
Cell-Free DNA for Genomic Analysis in Primary Mediastinal Large B-Cell Lymphoma. |
NFKBIE |
2 |
35964234 |
10.1093/ajcp/aqac087 |
2022 |
Histiocytic Sarcoma With CCND1 Gene Rearrangement Clonally Related and Transdifferentiated From Mantle Cell Lymphoma. |
NFKBIE |
3 |
32079702 |
10.3324/haematol.2019.237719 |
2021 |
Targeted genotyping of circulating tumor DNA for classical Hodgkin lymphoma monitoring: a prospective study. |
NFKBIE |
4 |
32961552 |
10.1182/blood.2020007507 |
2021 |
Mutational landscape of gray zone lymphoma. |
NFKBIE |
5 |
34405005 |
10.7150/jca.60390 |
2021 |
Serial surveillance by circulating tumor DNA profiling after chimeric antigen receptor T therapy for the guidance of r/r diffuse large B cell lymphoma precise treatment. |
NFKBIE |
6 |
32012328 |
10.1002/hon.2718 |
2020 |
High throughput sequencing reveals high specificity of TNFAIP3 mutations in ocular adnexal marginal zone B-cell lymphomas. |
NFKBIE |
7 |
32585984 |
10.3390/cancers12061669 |
2020 |
Discovery of Novel Recurrent Mutations and Clinically Meaningful Subgroups in Nodal Marginal Zone Lymphoma. |
NFKBIE |
8 |
32947237 |
10.1016/j.tranon.2020.100855 |
2020 |
Identification of clinical molecular targets for childhood Burkitt lymphoma. |
NFKBIE |
9 |
29857068 |
10.1016/j.jid.2018.04.038 |
2018 |
Genomic Analyses Identify Recurrent Alterations in Immune Evasion Genes in Diffuse Large B-Cell Lymphoma, Leg Type. |
NFKBIE |
10 |
29899297 |
10.3390/ijms19061758 |
2018 |
Molecular Mechanisms of Disease Progression in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type during Ibrutinib Therapy. |
NFKBIE |
11 |
26647218 |
10.1158/1078-0432.CCR-15-2123 |
2016 |
Genetic Landscapes of Relapsed and Refractory Diffuse Large B-Cell Lymphomas. |
NFKBIE |
12 |
19573080 |
10.1111/j.1365-2141.2009.07790.x |
2009 |
Common genetic variants in candidate genes and risk of familial lymphoid malignancies. |
NFKBIE |
13 |
19773279 |
10.1136/oem.2008.044024 |
2009 |
Association between genetic variants in VEGF, ERCC3 and occupational benzene haematotoxicity. |
NFKBIE |